kabutan

Human Metabolome Technologies, Inc.(6090) Summary

6090
TSE Standard
Human Metabolome Technologies, Inc.
696
JPY
0
(0.00%)
Apr 30, 9:00 am JST
4.34
USD
Apr 29, 8:00 pm EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
14.8
PBR
2.14
Yield
2.59%
Margin Trading Ratio
Stock Price
Apr 30, 2026
Opening Apr 30, 9:00 am
696 JPY 4.34 USD
Previous Close Apr 28
696 JPY 4.37 USD
High Apr 30, 9:00 am
696 JPY 4.34 USD
Low Apr 30, 9:00 am
696 JPY 4.34 USD
Volume
2,300
Trading Value
2.00M JPY 9.99K USD
VWAP
696.0 JPY 4.34 USD
Minimum Trading Value
69,600 JPY 434 USD
Market Cap
4.12B JPY 0.03B USD
Number of Trades
1
Liquidity & Number of Trades
As of Apr 30, 2026
Liquidity
Slightly Low
1-Year Average
37
1-Year High Jul 1, 2025
282
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 0 201,600
Apr 17, 2026 0 206,000
Apr 10, 2026 0 209,800
Apr 3, 2026 0 214,200
Mar 27, 2026 0 213,700
Company Profile
Human Metabolome Technologies, Inc. is a biotech venture company originating from Keio University. The company specializes in metabolite analysis services and biomarker detection.
Sector
Services
Human Metabolome Technologies develops businesses utilizing metabolome analysis and biotechnology. Through its comprehensive metabolite analysis technology using CE-MS method, the company engages in two main business areas: advanced research and development support, and healthcare solutions. In the former, the company provides metabolome analysis services to food, chemical, and pharmaceutical companies, as well as research institutions. In the latter, it supports the development of functional materials.